nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—XDH—Azathioprine—systemic lupus erythematosus	0.777	1	CbGbCtD
Deferoxamine—Angioedema—Triamcinolone—systemic lupus erythematosus	0.000274	0.00123	CcSEcCtD
Deferoxamine—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.000273	0.00122	CcSEcCtD
Deferoxamine—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.000272	0.00122	CcSEcCtD
Deferoxamine—Erythema—Betamethasone—systemic lupus erythematosus	0.000272	0.00122	CcSEcCtD
Deferoxamine—Erythema—Dexamethasone—systemic lupus erythematosus	0.000272	0.00122	CcSEcCtD
Deferoxamine—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.000271	0.00121	CcSEcCtD
Deferoxamine—Hallucination—Prednisone—systemic lupus erythematosus	0.00027	0.00121	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000269	0.0012	CcSEcCtD
Deferoxamine—Pruritus—Leflunomide—systemic lupus erythematosus	0.000268	0.0012	CcSEcCtD
Deferoxamine—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.000267	0.0012	CcSEcCtD
Deferoxamine—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000266	0.00119	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000266	0.00119	CcSEcCtD
Deferoxamine—Oedema—Prednisolone—systemic lupus erythematosus	0.000266	0.00119	CcSEcCtD
Deferoxamine—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000266	0.00119	CcSEcCtD
Deferoxamine—Dysuria—Methotrexate—systemic lupus erythematosus	0.000265	0.00119	CcSEcCtD
Deferoxamine—Dizziness—Azathioprine—systemic lupus erythematosus	0.000265	0.00119	CcSEcCtD
Deferoxamine—Paraesthesia—Cyclosporine—systemic lupus erythematosus	0.000262	0.00117	CcSEcCtD
Deferoxamine—Shock—Prednisolone—systemic lupus erythematosus	0.000261	0.00117	CcSEcCtD
Deferoxamine—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.00026	0.00117	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000259	0.00116	CcSEcCtD
Deferoxamine—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000259	0.00116	CcSEcCtD
Deferoxamine—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000259	0.00116	CcSEcCtD
Deferoxamine—Convulsion—Triamcinolone—systemic lupus erythematosus	0.000259	0.00116	CcSEcCtD
Deferoxamine—Tachycardia—Prednisolone—systemic lupus erythematosus	0.000259	0.00116	CcSEcCtD
Deferoxamine—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000259	0.00116	CcSEcCtD
Deferoxamine—Convulsion—Methylprednisolone—systemic lupus erythematosus	0.000259	0.00116	CcSEcCtD
Deferoxamine—Infection—Hydrocortisone—systemic lupus erythematosus	0.000258	0.00116	CcSEcCtD
Deferoxamine—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.000256	0.00115	CcSEcCtD
Deferoxamine—Shock—Hydrocortisone—systemic lupus erythematosus	0.000255	0.00114	CcSEcCtD
Deferoxamine—Myalgia—Triamcinolone—systemic lupus erythematosus	0.000255	0.00114	CcSEcCtD
Deferoxamine—Vomiting—Azathioprine—systemic lupus erythematosus	0.000255	0.00114	CcSEcCtD
Deferoxamine—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000254	0.00114	CcSEcCtD
Deferoxamine—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000254	0.00114	CcSEcCtD
Deferoxamine—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.000254	0.00114	CcSEcCtD
Deferoxamine—Eye disorder—Prednisone—systemic lupus erythematosus	0.000254	0.00114	CcSEcCtD
Deferoxamine—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000254	0.00114	CcSEcCtD
Deferoxamine—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.000253	0.00113	CcSEcCtD
Deferoxamine—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000253	0.00113	CcSEcCtD
Deferoxamine—Infestation—Methotrexate—systemic lupus erythematosus	0.000253	0.00113	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000253	0.00113	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000252	0.00113	CcSEcCtD
Deferoxamine—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000252	0.00113	CcSEcCtD
Deferoxamine—Headache—Azathioprine—systemic lupus erythematosus	0.000251	0.00112	CcSEcCtD
Deferoxamine—Dizziness—Leflunomide—systemic lupus erythematosus	0.00025	0.00112	CcSEcCtD
Deferoxamine—Pain—Cyclosporine—systemic lupus erythematosus	0.00025	0.00112	CcSEcCtD
Deferoxamine—Renal failure—Methotrexate—systemic lupus erythematosus	0.000249	0.00111	CcSEcCtD
Deferoxamine—Angioedema—Betamethasone—systemic lupus erythematosus	0.000248	0.00111	CcSEcCtD
Deferoxamine—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000248	0.00111	CcSEcCtD
Deferoxamine—Angiopathy—Prednisone—systemic lupus erythematosus	0.000247	0.0011	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000246	0.0011	CcSEcCtD
Deferoxamine—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000245	0.0011	CcSEcCtD
Deferoxamine—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000244	0.00109	CcSEcCtD
Deferoxamine—Oedema—Triamcinolone—systemic lupus erythematosus	0.000244	0.00109	CcSEcCtD
Deferoxamine—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000244	0.00109	CcSEcCtD
Deferoxamine—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000244	0.00109	CcSEcCtD
Deferoxamine—Arrhythmia—Prednisone—systemic lupus erythematosus	0.000243	0.00109	CcSEcCtD
Deferoxamine—Infection—Triamcinolone—systemic lupus erythematosus	0.000243	0.00109	CcSEcCtD
Deferoxamine—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000242	0.00109	CcSEcCtD
Deferoxamine—Infection—Methylprednisolone—systemic lupus erythematosus	0.000242	0.00109	CcSEcCtD
Deferoxamine—Vomiting—Leflunomide—systemic lupus erythematosus	0.000241	0.00108	CcSEcCtD
Deferoxamine—Shock—Triamcinolone—systemic lupus erythematosus	0.00024	0.00108	CcSEcCtD
Deferoxamine—Shock—Methylprednisolone—systemic lupus erythematosus	0.00024	0.00107	CcSEcCtD
Deferoxamine—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000239	0.00107	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000239	0.00107	CcSEcCtD
Deferoxamine—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000239	0.00107	CcSEcCtD
Deferoxamine—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000238	0.00107	CcSEcCtD
Deferoxamine—Nausea—Azathioprine—systemic lupus erythematosus	0.000238	0.00107	CcSEcCtD
Deferoxamine—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000238	0.00107	CcSEcCtD
Deferoxamine—Headache—Leflunomide—systemic lupus erythematosus	0.000237	0.00106	CcSEcCtD
Deferoxamine—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000237	0.00106	CcSEcCtD
Deferoxamine—Erythema—Prednisone—systemic lupus erythematosus	0.000237	0.00106	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000236	0.00106	CcSEcCtD
Deferoxamine—Convulsion—Betamethasone—systemic lupus erythematosus	0.000235	0.00105	CcSEcCtD
Deferoxamine—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000235	0.00105	CcSEcCtD
Deferoxamine—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000233	0.00104	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000233	0.00104	CcSEcCtD
Deferoxamine—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000232	0.00104	CcSEcCtD
Deferoxamine—Myalgia—Betamethasone—systemic lupus erythematosus	0.000231	0.00104	CcSEcCtD
Deferoxamine—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000231	0.00104	CcSEcCtD
Deferoxamine—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000231	0.00103	CcSEcCtD
Deferoxamine—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000231	0.00103	CcSEcCtD
Deferoxamine—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000228	0.00102	CcSEcCtD
Deferoxamine—Pain—Prednisolone—systemic lupus erythematosus	0.000227	0.00102	CcSEcCtD
Deferoxamine—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000226	0.00101	CcSEcCtD
Deferoxamine—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000225	0.00101	CcSEcCtD
Deferoxamine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000225	0.00101	CcSEcCtD
Deferoxamine—Nausea—Leflunomide—systemic lupus erythematosus	0.000225	0.00101	CcSEcCtD
Deferoxamine—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000224	0.001	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000224	0.001	CcSEcCtD
Deferoxamine—Vision blurred—Prednisone—systemic lupus erythematosus	0.000223	0.000999	CcSEcCtD
Deferoxamine—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000223	0.000997	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000223	0.000997	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000222	0.000995	CcSEcCtD
Deferoxamine—Pain—Hydrocortisone—systemic lupus erythematosus	0.000222	0.000994	CcSEcCtD
Deferoxamine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000222	0.000993	CcSEcCtD
Deferoxamine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000222	0.000993	CcSEcCtD
Deferoxamine—Oedema—Betamethasone—systemic lupus erythematosus	0.000222	0.000993	CcSEcCtD
Deferoxamine—Oedema—Dexamethasone—systemic lupus erythematosus	0.000222	0.000993	CcSEcCtD
Deferoxamine—Infection—Dexamethasone—systemic lupus erythematosus	0.00022	0.000987	CcSEcCtD
Deferoxamine—Infection—Betamethasone—systemic lupus erythematosus	0.00022	0.000987	CcSEcCtD
Deferoxamine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000219	0.000983	CcSEcCtD
Deferoxamine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000219	0.000981	CcSEcCtD
Deferoxamine—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000219	0.000981	CcSEcCtD
Deferoxamine—Shock—Betamethasone—systemic lupus erythematosus	0.000218	0.000977	CcSEcCtD
Deferoxamine—Shock—Dexamethasone—systemic lupus erythematosus	0.000218	0.000977	CcSEcCtD
Deferoxamine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000218	0.000976	CcSEcCtD
Deferoxamine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000217	0.000974	CcSEcCtD
Deferoxamine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000217	0.000974	CcSEcCtD
Deferoxamine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000217	0.000973	CcSEcCtD
Deferoxamine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000217	0.000973	CcSEcCtD
Deferoxamine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000216	0.000969	CcSEcCtD
Deferoxamine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000216	0.000969	CcSEcCtD
Deferoxamine—Angioedema—Prednisone—systemic lupus erythematosus	0.000216	0.000968	CcSEcCtD
Deferoxamine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000215	0.000964	CcSEcCtD
Deferoxamine—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000212	0.000951	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000212	0.000951	CcSEcCtD
Deferoxamine—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000212	0.000949	CcSEcCtD
Deferoxamine—Urticaria—Prednisolone—systemic lupus erythematosus	0.000211	0.000946	CcSEcCtD
Deferoxamine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.00021	0.00094	CcSEcCtD
Deferoxamine—Pain—Triamcinolone—systemic lupus erythematosus	0.000209	0.000936	CcSEcCtD
Deferoxamine—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000207	0.000928	CcSEcCtD
Deferoxamine—Hypotension—Betamethasone—systemic lupus erythematosus	0.000207	0.000928	CcSEcCtD
Deferoxamine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000207	0.000926	CcSEcCtD
Deferoxamine—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000206	0.000924	CcSEcCtD
Deferoxamine—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000206	0.000923	CcSEcCtD
Deferoxamine—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000205	0.000919	CcSEcCtD
Deferoxamine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000205	0.000919	CcSEcCtD
Deferoxamine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000205	0.000919	CcSEcCtD
Deferoxamine—Convulsion—Prednisone—systemic lupus erythematosus	0.000205	0.000918	CcSEcCtD
Deferoxamine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000205	0.000917	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000202	0.000905	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000202	0.000905	CcSEcCtD
Deferoxamine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000201	0.000903	CcSEcCtD
Deferoxamine—Arthralgia—Prednisone—systemic lupus erythematosus	0.000201	0.000902	CcSEcCtD
Deferoxamine—Myalgia—Prednisone—systemic lupus erythematosus	0.000201	0.000902	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.0002	0.000896	CcSEcCtD
Deferoxamine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.0002	0.000895	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000199	0.000893	CcSEcCtD
Deferoxamine—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000199	0.000892	CcSEcCtD
Deferoxamine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000199	0.000892	CcSEcCtD
Deferoxamine—Erythema—Methotrexate—systemic lupus erythematosus	0.000198	0.000886	CcSEcCtD
Deferoxamine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000196	0.000877	CcSEcCtD
Deferoxamine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000195	0.000873	CcSEcCtD
Deferoxamine—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000194	0.00087	CcSEcCtD
Deferoxamine—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000194	0.000868	CcSEcCtD
Deferoxamine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000193	0.000865	CcSEcCtD
Deferoxamine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000193	0.000865	CcSEcCtD
Deferoxamine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000193	0.000865	CcSEcCtD
Deferoxamine—Oedema—Prednisone—systemic lupus erythematosus	0.000193	0.000865	CcSEcCtD
Deferoxamine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000193	0.000863	CcSEcCtD
Deferoxamine—Infection—Prednisone—systemic lupus erythematosus	0.000192	0.000859	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000191	0.000858	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000191	0.000858	CcSEcCtD
Deferoxamine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000191	0.000857	CcSEcCtD
Deferoxamine—Shock—Prednisone—systemic lupus erythematosus	0.00019	0.000851	CcSEcCtD
Deferoxamine—Pain—Dexamethasone—systemic lupus erythematosus	0.00019	0.000849	CcSEcCtD
Deferoxamine—Pain—Betamethasone—systemic lupus erythematosus	0.00019	0.000849	CcSEcCtD
Deferoxamine—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000189	0.000848	CcSEcCtD
Deferoxamine—Tachycardia—Prednisone—systemic lupus erythematosus	0.000188	0.000844	CcSEcCtD
Deferoxamine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000188	0.000844	CcSEcCtD
Deferoxamine—Skin disorder—Prednisone—systemic lupus erythematosus	0.000188	0.00084	CcSEcCtD
Deferoxamine—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000186	0.000835	CcSEcCtD
Deferoxamine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000186	0.000832	CcSEcCtD
Deferoxamine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000184	0.000823	CcSEcCtD
Deferoxamine—Headache—Cyclosporine—systemic lupus erythematosus	0.000183	0.00082	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000181	0.000812	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000181	0.000812	CcSEcCtD
Deferoxamine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000181	0.000811	CcSEcCtD
Deferoxamine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.00018	0.000807	CcSEcCtD
Deferoxamine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.00018	0.000805	CcSEcCtD
Deferoxamine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000178	0.000799	CcSEcCtD
Deferoxamine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000178	0.000795	CcSEcCtD
Deferoxamine—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000177	0.000793	CcSEcCtD
Deferoxamine—Urticaria—Betamethasone—systemic lupus erythematosus	0.000176	0.000789	CcSEcCtD
Deferoxamine—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000176	0.000789	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000176	0.000788	CcSEcCtD
Deferoxamine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000176	0.000787	CcSEcCtD
Deferoxamine—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000175	0.000785	CcSEcCtD
Deferoxamine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000175	0.000785	CcSEcCtD
Deferoxamine—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000175	0.000785	CcSEcCtD
Deferoxamine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000175	0.000785	CcSEcCtD
Deferoxamine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000173	0.000777	CcSEcCtD
Deferoxamine—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000173	0.000777	CcSEcCtD
Deferoxamine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000173	0.000775	CcSEcCtD
Deferoxamine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000172	0.000773	CcSEcCtD
Deferoxamine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000172	0.000769	CcSEcCtD
Deferoxamine—Convulsion—Methotrexate—systemic lupus erythematosus	0.000171	0.000767	CcSEcCtD
Deferoxamine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000169	0.000758	CcSEcCtD
Deferoxamine—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000168	0.000754	CcSEcCtD
Deferoxamine—Myalgia—Methotrexate—systemic lupus erythematosus	0.000168	0.000754	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000167	0.000749	CcSEcCtD
Deferoxamine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000167	0.000747	CcSEcCtD
Deferoxamine—Headache—Prednisolone—systemic lupus erythematosus	0.000166	0.000746	CcSEcCtD
Deferoxamine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000165	0.000739	CcSEcCtD
Deferoxamine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000163	0.000728	CcSEcCtD
Deferoxamine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000162	0.000724	CcSEcCtD
Deferoxamine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000161	0.000723	CcSEcCtD
Deferoxamine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000161	0.000722	CcSEcCtD
Deferoxamine—Infection—Methotrexate—systemic lupus erythematosus	0.00016	0.000718	CcSEcCtD
Deferoxamine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000158	0.000709	CcSEcCtD
Deferoxamine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000158	0.000708	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000158	0.000707	CcSEcCtD
Deferoxamine—Nausea—Prednisolone—systemic lupus erythematosus	0.000158	0.000707	CcSEcCtD
Deferoxamine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000157	0.000703	CcSEcCtD
Deferoxamine—Pruritus—Betamethasone—systemic lupus erythematosus	0.000157	0.000703	CcSEcCtD
Deferoxamine—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000157	0.000702	CcSEcCtD
Deferoxamine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000155	0.000696	CcSEcCtD
Deferoxamine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000155	0.000695	CcSEcCtD
Deferoxamine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000154	0.000691	CcSEcCtD
Deferoxamine—Urticaria—Prednisone—systemic lupus erythematosus	0.000153	0.000687	CcSEcCtD
Deferoxamine—Headache—Triamcinolone—systemic lupus erythematosus	0.000153	0.000686	CcSEcCtD
Deferoxamine—Headache—Methylprednisolone—systemic lupus erythematosus	0.000153	0.000684	CcSEcCtD
Deferoxamine—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000153	0.000684	CcSEcCtD
Deferoxamine—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000153	0.000684	CcSEcCtD
Deferoxamine—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000152	0.00068	CcSEcCtD
Deferoxamine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000152	0.00068	CcSEcCtD
Deferoxamine—Hypotension—Methotrexate—systemic lupus erythematosus	0.000151	0.000676	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000147	0.000659	CcSEcCtD
Deferoxamine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000147	0.000657	CcSEcCtD
Deferoxamine—Dizziness—Betamethasone—systemic lupus erythematosus	0.000147	0.000657	CcSEcCtD
Deferoxamine—Nausea—Triamcinolone—systemic lupus erythematosus	0.000145	0.00065	CcSEcCtD
Deferoxamine—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000145	0.000649	CcSEcCtD
Deferoxamine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000145	0.000649	CcSEcCtD
Deferoxamine—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000144	0.000645	CcSEcCtD
Deferoxamine—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000142	0.000637	CcSEcCtD
Deferoxamine—Vomiting—Betamethasone—systemic lupus erythematosus	0.000141	0.000632	CcSEcCtD
Deferoxamine—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000141	0.000632	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000139	0.000624	CcSEcCtD
Deferoxamine—Headache—Betamethasone—systemic lupus erythematosus	0.000139	0.000622	CcSEcCtD
Deferoxamine—Headache—Dexamethasone—systemic lupus erythematosus	0.000139	0.000622	CcSEcCtD
Deferoxamine—Pain—Methotrexate—systemic lupus erythematosus	0.000138	0.000618	CcSEcCtD
Deferoxamine—Pruritus—Prednisone—systemic lupus erythematosus	0.000137	0.000612	CcSEcCtD
Deferoxamine—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000132	0.000592	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000132	0.000591	CcSEcCtD
Deferoxamine—Nausea—Betamethasone—systemic lupus erythematosus	0.000132	0.00059	CcSEcCtD
Deferoxamine—Nausea—Dexamethasone—systemic lupus erythematosus	0.000132	0.00059	CcSEcCtD
Deferoxamine—Urticaria—Methotrexate—systemic lupus erythematosus	0.000128	0.000574	CcSEcCtD
Deferoxamine—Dizziness—Prednisone—systemic lupus erythematosus	0.000128	0.000572	CcSEcCtD
Deferoxamine—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000128	0.000572	CcSEcCtD
Deferoxamine—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000128	0.000572	CcSEcCtD
Deferoxamine—Vomiting—Prednisone—systemic lupus erythematosus	0.000123	0.00055	CcSEcCtD
Deferoxamine—Headache—Prednisone—systemic lupus erythematosus	0.000121	0.000542	CcSEcCtD
Deferoxamine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000119	0.000533	CcSEcCtD
Deferoxamine—Nausea—Prednisone—systemic lupus erythematosus	0.000115	0.000514	CcSEcCtD
Deferoxamine—Pruritus—Methotrexate—systemic lupus erythematosus	0.000114	0.000511	CcSEcCtD
Deferoxamine—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.00011	0.000495	CcSEcCtD
Deferoxamine—Dizziness—Methotrexate—systemic lupus erythematosus	0.000107	0.000478	CcSEcCtD
Deferoxamine—Vomiting—Methotrexate—systemic lupus erythematosus	0.000103	0.00046	CcSEcCtD
Deferoxamine—Headache—Methotrexate—systemic lupus erythematosus	0.000101	0.000453	CcSEcCtD
Deferoxamine—Nausea—Methotrexate—systemic lupus erythematosus	9.58e-05	0.000429	CcSEcCtD
